Washington, D.C. March 30, 2020. The  American Institute for Medical and Biological Engineering (AIMBE) has announced the induction of Jörg Breitenbach, Ph.D., MBA, Founder and Scientific Advisor, BIT Pharma to its College of Fellows. The College of Fellows is comprised of the top two percent of medical and biological engineer. Dr. Breitenbach was nominated, reviewed […]

Washington, D.C. March 30, 2020.

The  American Institute for Medical and Biological Engineering (AIMBE) has announced the induction of Jörg Breitenbach, Ph.D., MBA, Founder and Scientific Advisor, BIT Pharma to its College of Fellows. The College of Fellows is comprised of the top two percent of medical and biological engineer.

Dr. Breitenbach was nominated, reviewed and elected for ‘outstanding contributions in development and commercialization of patient centric polymer based dosage forms in infectious diseases and neurological interventions’.

Link to the press release: aimbe-nomination-and-press-rel

Contact Us

Send us an email for further inquiry.

Not readable? Change text.